Recently, a novel lncRNA named SKAI1BC (Suppressor of KAI1 in Breast Carcinoma) has been shown to epigenetically inactivate the anti-oncogenic activity of KAI/CD82 in breast cancer [102]. This evidence concerns the gene CD82 and breast cancer.